The response to BTK inhibitors correlated with a moderate effect of the BTK knock-out on BJAB and BL-60, in line with the survival signals in BL and GCB-DLBCL stemming from BCR signalling. The gene discussed is BTK; the disease is Burkitt lymphoma.